Atlas Venture Fund VII L P 13D/13G Filings for Viridian Therapeutics, Inc. (VRDN)

Atlas Venture Fund VII L P 13D and 13G filings for Viridian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-06-14
4:15 pm
Unchanged		2023-05-2313DViridian Therapeutics, Inc.
VRDN		Atlas Venture Fund VII L P0
0.000%		0
(Unchanged)		Filing